64E-21842-34984
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 500 / IA
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-02-18
Registered in v-safe
-
2021-02-18
Dose 2 — Pfizer-BioNTech
-
2021-02-18
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · None · Be unable to workAdult check-in
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-20
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Musculoskeletal stiffness — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Stiff neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-23
- 2021-02-24
- 2022-02-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-18 | priority 2/3 | |
| 2021-02-21 | priority 2/3 |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Stiff neck
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release